| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |